Cannabis advocates’ efforts to ease regulations surrounding the drug reached a new high last month when the Trump administration announced it would reschedule medical marijuana under a less strict category. State medical marijuana products will be moved from Schedule I, the most regulated category, for drugs like heroin with no medical use and high potential for abuse, to Schedule III, for drugs with low potential for abuse like Tylenol with codeine and testosterone, according to an April 23 order from the Department of Justice. The order also moves FDA-approved products that contain marijuana to the less-regulated category, though only a few such products have been greenlit by the agency. Though the decision to reschedule medical marijuana isn’t expected to have a major impact on employers for now, it could pave the way for more employees to request accommodations under the Americans with Disabilities Act, legal experts told HR Brew. For more on why rescheduling marijuana could prompt more ADA requests, keep reading here.—CV |